Search

everythinglearnresearchcommunity

for

Search:↓

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Monoclonal antibodies are often linked to alopecia areata cases.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

ACA from Alpinia galanga may prevent testosterone-related hair loss.

The inhibitor affects androgen metabolism but not ovarian function.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Baricitinib effectively promotes regrowth of eyebrows and eyelashes in alopecia areata patients.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.